Cargando…

Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer

BACKGROUND: The most important consideration in determining treatment strategies for undifferentiated early gastric cancer (UEGC) is the risk of lymph node metastasis (LNM). Therefore, identifying a potential biomarker that predicts LNM is quite useful in determining treatment. AIM: To develop a mac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Xin, Yan, Xue-Jiao, Guo, Yu-Yan, Zhang, Jie, Wang, Guo-Rong, Fayyaz, Arsalan, Yu, Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521518/
https://www.ncbi.nlm.nih.gov/pubmed/36185632
http://dx.doi.org/10.3748/wjg.v28.i36.5338
_version_ 1784799857015259136
author Wei, Xin
Yan, Xue-Jiao
Guo, Yu-Yan
Zhang, Jie
Wang, Guo-Rong
Fayyaz, Arsalan
Yu, Jiao
author_facet Wei, Xin
Yan, Xue-Jiao
Guo, Yu-Yan
Zhang, Jie
Wang, Guo-Rong
Fayyaz, Arsalan
Yu, Jiao
author_sort Wei, Xin
collection PubMed
description BACKGROUND: The most important consideration in determining treatment strategies for undifferentiated early gastric cancer (UEGC) is the risk of lymph node metastasis (LNM). Therefore, identifying a potential biomarker that predicts LNM is quite useful in determining treatment. AIM: To develop a machine learning (ML)-based integral procedure to construct the LNM gray-level co-occurrence matrix (GLCM) prediction model. METHODS: We retrospectively selected 526 cases of UEGC confirmed through pathological examination after radical gastrectomy without endoscopic treatment in four tertiary hospitals between January 2015 to December 2021. We extracted GLCM-based features from grayscale images and applied ML to the classification of candidate predictive variables. The robustness and clinical utility of each model were evaluated based on the following factors: Receiver operating characteristic curve (ROC), decision curve analysis, and clinical impact curve. RESULTS: GLCM-based feature extraction significantly correlated with LNM. The top 7 GLCM-based factors included inertia value 0° (IV_0), inertia value 45° (IV_45), inverse gap 0° (IG_0), inverse gap 45° (IG_45), inverse gap full angle (IG_all), Haralick 30° (Haralick_30), Haralick full angle (Haralick_all), and Entropy. The areas under the ROC curve (AUCs) of the random forest classifier (RFC) model, support vector machine, eXtreme gradient boosting, artificial neural network, and decision tree ranged from 0.805 [95% confidence interval (CI): 0.258-1.352] to 0.925 (95%CI: 0.378-1.472) in the training set and from 0.794 (95%CI: 0.237-1.351) to 0.912 (95%CI: 0.355-1.469) in the testing set, respectively. The RFC (training set: AUC: 0.925, 95%CI: 0.378-1.472; testing set: AUC: 0.912, 95%CI: 0.355-1.469) model that incorporates Entropy, Haralick_all, Haralick_30, IG_all, IG_45, IG_0, and IV_45 had the highest predictive accuracy. CONCLUSION: The evaluation results indicate that the method of selecting radiological and textural features becomes more effective in the LNM discrimination against UEGC patients. Additionally, the ML-based prediction model developed using the RFC can be used to derive treatment options and identify LNM, which can hence improve clinical outcomes.
format Online
Article
Text
id pubmed-9521518
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-95215182022-09-30 Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer Wei, Xin Yan, Xue-Jiao Guo, Yu-Yan Zhang, Jie Wang, Guo-Rong Fayyaz, Arsalan Yu, Jiao World J Gastroenterol Retrospective Cohort Study BACKGROUND: The most important consideration in determining treatment strategies for undifferentiated early gastric cancer (UEGC) is the risk of lymph node metastasis (LNM). Therefore, identifying a potential biomarker that predicts LNM is quite useful in determining treatment. AIM: To develop a machine learning (ML)-based integral procedure to construct the LNM gray-level co-occurrence matrix (GLCM) prediction model. METHODS: We retrospectively selected 526 cases of UEGC confirmed through pathological examination after radical gastrectomy without endoscopic treatment in four tertiary hospitals between January 2015 to December 2021. We extracted GLCM-based features from grayscale images and applied ML to the classification of candidate predictive variables. The robustness and clinical utility of each model were evaluated based on the following factors: Receiver operating characteristic curve (ROC), decision curve analysis, and clinical impact curve. RESULTS: GLCM-based feature extraction significantly correlated with LNM. The top 7 GLCM-based factors included inertia value 0° (IV_0), inertia value 45° (IV_45), inverse gap 0° (IG_0), inverse gap 45° (IG_45), inverse gap full angle (IG_all), Haralick 30° (Haralick_30), Haralick full angle (Haralick_all), and Entropy. The areas under the ROC curve (AUCs) of the random forest classifier (RFC) model, support vector machine, eXtreme gradient boosting, artificial neural network, and decision tree ranged from 0.805 [95% confidence interval (CI): 0.258-1.352] to 0.925 (95%CI: 0.378-1.472) in the training set and from 0.794 (95%CI: 0.237-1.351) to 0.912 (95%CI: 0.355-1.469) in the testing set, respectively. The RFC (training set: AUC: 0.925, 95%CI: 0.378-1.472; testing set: AUC: 0.912, 95%CI: 0.355-1.469) model that incorporates Entropy, Haralick_all, Haralick_30, IG_all, IG_45, IG_0, and IV_45 had the highest predictive accuracy. CONCLUSION: The evaluation results indicate that the method of selecting radiological and textural features becomes more effective in the LNM discrimination against UEGC patients. Additionally, the ML-based prediction model developed using the RFC can be used to derive treatment options and identify LNM, which can hence improve clinical outcomes. Baishideng Publishing Group Inc 2022-09-28 2022-09-28 /pmc/articles/PMC9521518/ /pubmed/36185632 http://dx.doi.org/10.3748/wjg.v28.i36.5338 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Cohort Study
Wei, Xin
Yan, Xue-Jiao
Guo, Yu-Yan
Zhang, Jie
Wang, Guo-Rong
Fayyaz, Arsalan
Yu, Jiao
Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer
title Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer
title_full Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer
title_fullStr Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer
title_full_unstemmed Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer
title_short Machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer
title_sort machine learning-based gray-level co-occurrence matrix signature for predicting lymph node metastasis in undifferentiated-type early gastric cancer
topic Retrospective Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521518/
https://www.ncbi.nlm.nih.gov/pubmed/36185632
http://dx.doi.org/10.3748/wjg.v28.i36.5338
work_keys_str_mv AT weixin machinelearningbasedgraylevelcooccurrencematrixsignatureforpredictinglymphnodemetastasisinundifferentiatedtypeearlygastriccancer
AT yanxuejiao machinelearningbasedgraylevelcooccurrencematrixsignatureforpredictinglymphnodemetastasisinundifferentiatedtypeearlygastriccancer
AT guoyuyan machinelearningbasedgraylevelcooccurrencematrixsignatureforpredictinglymphnodemetastasisinundifferentiatedtypeearlygastriccancer
AT zhangjie machinelearningbasedgraylevelcooccurrencematrixsignatureforpredictinglymphnodemetastasisinundifferentiatedtypeearlygastriccancer
AT wangguorong machinelearningbasedgraylevelcooccurrencematrixsignatureforpredictinglymphnodemetastasisinundifferentiatedtypeearlygastriccancer
AT fayyazarsalan machinelearningbasedgraylevelcooccurrencematrixsignatureforpredictinglymphnodemetastasisinundifferentiatedtypeearlygastriccancer
AT yujiao machinelearningbasedgraylevelcooccurrencematrixsignatureforpredictinglymphnodemetastasisinundifferentiatedtypeearlygastriccancer